Fire Damages Albion Facility

CLEARFIELD, Utah – July 26, 2016 – An fire swept through the Balchem facility located in Clearfield, Utah on July 25, 2016. The facility serves as the headquarters for Albion Minerals and is also a product granulation and blending facility where some of Albion’s human products are produced. Safety is always our primary concern and we are pleased to confirm that all employees that were on-site at the time of the fire were safely evacuated.

Unfortunately, the fire was extensive and both our offices and our manufacturing facility have suffered damages. The cause of the fire is still unknown, and we are cooperating with local authorities who are conducting a full investigation.

Electricity and communication systems were temporarily interrupted by the fire. We are working to rapidly restore these systems, and take the necessary actions to continue service to our valued customers.

Albion has the full support and resources of our parent company, Balchem Corporation. We are working together to resume normal operations as expeditiously as possible. The company has an established business continuity plan, and our team is taking immediate steps to ensure continued supply and service for all of our customers. We will be proactively reaching out to our customers to discuss future and existing requirements as we plan this transition.

Leveraging the capacity of our expanded manufacturing network, we are already re-assigning production as needed. Although we face some short-term challenges from this event, we are confident in our capacity and commitment to meet our customers’ needs.

The latest information, updates and a FAQ will be available in the coming days on the www.AlbionMinerals.com website. Customers with immediate needs are encouraged to reach out to their sales representative or the director of customer care, Justine Angelico, at 801-391-8892 or at This email address is being protected from spambots. You need JavaScript enabled to view it..

We appreciate your continued support and patience. While this occurrence is certainly difficult, together we will rise above it and continue the Albion legacy of leadership and service. Thank you for your thoughts and well wishes.

 


 

Albion Acquired by Balchem Corporation

Balchem and Albion. CLEARFIELD, Utah – Feb. 8, 2016 – Albion International, Inc., a leading, privately held manufacturer of mineral amino acid chelates, is pleased to announce that it has been acquired by Balchem Corporation (BCPC). As world leaders and innovators in nutrition, the combined resources of both organizations will bring new opportunities to all customers. The product offerings, market position, and product development resources of both companies will be enhanced.

“For over 60 years, Albion has remained committed to quality research and development, and improving nutrition globally,” said James Hyde, CEO of Albion Minerals. “Aligning with Balchem will help drive global market growth and provide customers with an expanded portfolio of proven products and outstanding service. Albion is excited to be part of Balchem Corporation and we look forward to the future.”

With this acquisition, Balchem continues to expand its science-based human health and wellness solutions. Already the global leader in the essential nutrient choline, Balchem will immediately expand its nutritional ingredient offering by adding Albion’s branded, innovative chelated minerals to its portfolio. The combined company will also benefit from a broader geographic footprint and an even stronger position as a technological leader in spray-drying and ingredient delivery solutions.

Albion has been a world leader and innovator in the manufacture of superior organic mineral compounds for 60 years. With over 100 patents, Albion leverages scientific expertise in the areas of both human and plant nutrition. Albion’s products are renowned in the supplement industry for being technologically advanced, and having unparalleled bioavailability.

“We are very excited to add Albion’s deep scientific expertise, broad patent portfolio, and premium branded products to our company,” said Ted Harris, President and CEO of Balchem. “This acquisition creates a broader nutritional platform for Balchem that will help our customers improve their nutritional and wellness solutions.”

About Balchem
Balchem Corporation consists of four business segments: SensoryEffects; Animal Nutrition and Health; Specialty Products; and Industrial Products. The SensoryEffects segment provides customized food and beverage ingredient systems and proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition and Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and the Industrial Products segment, provides certain derivative products into industrial applications, predominately as a component for hydraulic fracturing of shale natural gas wells. For more information, visit www.balchem.com.

 


 

Balchem Corporation Acquires Albion International, Inc.

New Hampton, New York, February 1, 2016. Balchem Corporation (NASDAQ:BCPC) today announced that it acquired Albion International, Inc., a privately held manufacturer of mineral amino acid chelates, specialized mineral salts and mineral complexes, headquartered in Clearfield, Utah for a purchase price of $111.5 million in cash. Albion’s 2015 revenues were approximately $53.5 million. The acquisition purchase price reflects a multiple of approximately 10.7 times 2015 EBITDA, excluding any synergies. The transaction consideration is subject to certain adjustments as provided in the definitive agreement. The purchase price will be financed through the Company’s existing revolving credit facility and cash on hand. The transaction is expected to be immediately accretive to Balchem’s earnings per share.
 
Albion has been a world leader and innovator in the manufacture of superior organic mineral compounds for sixty years. With over 100 patents, Albion leverages scientific expertise in the areas of both human and plant nutrition. Albion’s products are renowned in the supplement industry for technologically advanced, unparalleled bioavailability.

With this acquisition, Balchem continues to expand its science based human health and wellness solutions. Already the global leader in the essential nutrient, choline, Balchem will immediately expand the combined company's product offerings in the nutritional ingredient market by adding Albion’s premier branded innovative chelated minerals to its portfolio. The combined company will also benefit from a broader geographic footprint and an even stronger position as a technological leader in spray-drying and ingredient delivery solutions.

“We are very excited to add Albion’s deep scientific expertise, broad patent portfolio, and premium branded products to our company. This acquisition creates a broader nutritional platform for Balchem that will help our customers improve their nutritional and wellness solutions,” said Ted Harris, President and CEO of Balchem.

 

Balchem logo.

About Balchem
Balchem Corporation consists of four business segments: SensoryEffects; Animal Nutrition and Health; Specialty Products; and Industrial Products. The SensoryEffects segment provides customized food and beverage ingredient systems and proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition and Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and the Industrial Products segment, provides certain derivative products into industrial applications, predominately as a component for hydraulic fracturing of shale natural gas wells.

 

Forward-Looking Statements
Any statements in this press release about future expectations, plans and prospects for Balchem or SensoryEffects and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations and risks and factors identified in Balchem’s annual report on Form 10-K for the year ended December 31, 2014. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date, except as required by law.


Balchem Contact:

Suzanne Hart, Investor Relations
Telephone:  845-326-5600
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

U.S. Senator Orrin Hatch highlighting Albion on the Senate floor. U.S. Senator Orrin Hatch highlighting Albion on the Senate floor